+32 3 369 17 40 info@etherna.be About eTheRNA Engineering the Future of mRNA eTheRNA immunotherapies is driving mRNA technology and therapeutic product development to deliver an innovative generation of RNA chemistries, RNA process technologies and a new and advanced generation of therapeutic and vaccine products. eTheRNA uses its established R&D foundations and in-house GMP manufacturing facilities and builds on its proprietary mRNA, mRNA adjuvant and mRNA formulation platforms to progress technology innovation and product development. eTheRNA was established in January 2013 as a spin-off company from the ‘Vrije Universiteit Brussel’ (VUB), following the development of its TriMix mRNA technology. // OUR COMPANY What We Do eTheRNA’s goal is to commercialize mRNA-based immunotherapies as off-the-shelf products for the treatment of cancer and infectious diseases. LEARN MORE Immunotherapies eTheRNA builds on more than 30 years of research grade mRNA manufacturing, and more than 5 years of GMP mRNA production. LEARN MORE Contract Manufacturing // STAY UP TO DATE Newsroom // 22 SEPTEMBER 2021 eTheRNA immunotherapies conference attendance for November 2021 Niel (Belgium) eTheRNA immunotherapies NV (‘eTheRNA’), a private clinical-stage biotechnology company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, will be attending the following conferences for November 2021: READ MORE DISCOVER ALL NEWS ARTICLES // OUR COMPANY Come Join Us Visit our careers site. WE'D LIKE TO HEAR FROM YOU CONTACT US Europe Corporate Headquarters — Galileilaan 19, 2845 Niel, Belgium Europe Discovery Facitlity — (as from Jan 3, 2022) Frieda Saeystraat 1B, 3rd floor, 9052 Zwijnaarde - Gent, Belgium North America 530 7th Avenue — Suite 902, New York, NY 10018 United States Asia-Pacific Unit 605-07, 6/F Wing on Center, 111 Connaught Road Central, Sheung Wan, Hong Kong info@etherna.be Our Mailbox +32 3 369 17 40 Our Phone Cookie settings © 2021 eTheRNA | Studio Hanswijk We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent. Cookie settingsACCEPT